Skip to main content

Table 1 Comparison of clinical parameters of acute stroke patients with positive thyroid autoantibody and those with negative thyroid autoantibody

From: Subclinical thyroid dysfunction and autoantibodies in acute ischemic and hemorrhagic stroke patients: relation to long term stroke outcome

Variables

Thyroid autoantibody

P value

Positive (N = 47)

Negative (N = 91)

Age, years

64.17 ± 12.46

64.55 ± 10.3

0.85

Sex

 Male, n (%)

21 (45%)

39(43%)

0.82

 Female, n (%)

26 (55%)

52(57%)

SBP, mmHg

116.9 ± 12.5

118.43 ± 12.23

0.49

DBP, mmHg

76.2 ± 7.9

77.3 ± 9.2

0.49

TC, mmol/L

5.20 ± 1.12

5.26 ± 1.13

0.77

LDL-C, mmol/L

3.37 ± 0.57

3.31 ± 0.81

0.65

HDL-C, mmol/L

1.22 ± 0.36

1.17 ± 0.32

0.41

TG, (mg/dL)

138.8 ± 76.2

127.8 ± 62.42

0.58

Initial free T4 level (pmol/L)

13.7 ± 2.7

14.01 ± 2.4

0.49

Final free T4 level (pmol/L)

14.9 ± 3.2

14.4 ± 3.1

0.37

Free T3 level (pmol/L)

4.11 ± 0.75

4.19 ± 0.73

0.55

Initial TSH level (mIU/mL)

1.64 ± 1.08

1.62 ± 1.13

0.92

Final TSH level (mIU/mL)

3.98 ± 0.58

3.74 ± 0.69

0.04*

Type of stroke

 Ischemic infarction

34 (72%)

74 (81%)

 

 Intracerebral hemorrhage

13 (28%)

17 (19%)

0.23

 NIHSS score at admission

10 ± 5

8 ± 2

0.001**

  1. BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, TC total cholesterol, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, TG triglycerides, T3 tri-iodothyronine, T4 thyroxin, TSH thyroid stimulating hormone, NIHSS National Institute of Health Stroke Scale
  2. Continuous data are represented in mean ± standard deviation; categorical data are represented in number and percentage
  3. **Highly significant